JP2005509634A5 - - Google Patents

Download PDF

Info

Publication number
JP2005509634A5
JP2005509634A5 JP2003537635A JP2003537635A JP2005509634A5 JP 2005509634 A5 JP2005509634 A5 JP 2005509634A5 JP 2003537635 A JP2003537635 A JP 2003537635A JP 2003537635 A JP2003537635 A JP 2003537635A JP 2005509634 A5 JP2005509634 A5 JP 2005509634A5
Authority
JP
Japan
Prior art keywords
formula
compound
amino
propanediol
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003537635A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005509634A (ja
Filing date
Publication date
Priority claimed from GBGB0125443.2A external-priority patent/GB0125443D0/en
Priority claimed from GB0127341A external-priority patent/GB0127341D0/en
Application filed filed Critical
Publication of JP2005509634A publication Critical patent/JP2005509634A/ja
Publication of JP2005509634A5 publication Critical patent/JP2005509634A5/ja
Pending legal-status Critical Current

Links

JP2003537635A 2001-10-23 2002-10-22 マクロライドを含む医薬組成物 Pending JP2005509634A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0125443.2A GB0125443D0 (en) 2001-10-23 2001-10-23 Organic Compounds
GB0127341A GB0127341D0 (en) 2001-11-14 2001-11-14 Organic compounds
PCT/EP2002/011799 WO2003035068A1 (en) 2001-10-23 2002-10-22 Macrolides containing pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2005509634A JP2005509634A (ja) 2005-04-14
JP2005509634A5 true JP2005509634A5 (enExample) 2008-04-10

Family

ID=26246689

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003537635A Pending JP2005509634A (ja) 2001-10-23 2002-10-22 マクロライドを含む医薬組成物

Country Status (19)

Country Link
US (1) US7259170B2 (enExample)
EP (1) EP1439838A1 (enExample)
JP (1) JP2005509634A (enExample)
KR (2) KR20090114483A (enExample)
CN (1) CN1307993C (enExample)
AU (1) AU2002346859C1 (enExample)
BR (1) BR0213463A (enExample)
CA (1) CA2458690C (enExample)
EC (1) ECSP045086A (enExample)
GB (1) GB0125443D0 (enExample)
HU (1) HUP0402108A3 (enExample)
IL (1) IL160973A0 (enExample)
MX (1) MXPA04003738A (enExample)
NO (1) NO20042074L (enExample)
NZ (1) NZ532412A (enExample)
PL (1) PL368533A1 (enExample)
RU (1) RU2321402C2 (enExample)
WO (1) WO2003035068A1 (enExample)
ZA (1) ZA200401711B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005512946A (ja) * 2001-05-09 2005-05-12 ノバルティス アクチエンゲゼルシャフト 選択的免疫調節法
MXPA04006709A (es) 2002-01-11 2004-10-04 Sankyo Co Derivados de aminoalcohol o derivados de acido fosfonico y composiciones farmaceuticas que los contienen.
GB0307867D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
KR20110136901A (ko) 2004-02-24 2011-12-21 상꾜 가부시키가이샤 아미노 알코올 화합물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68921934T2 (de) 1988-06-29 1995-10-19 Merck & Co Inc Immunsuppressives Agens.
ATE126803T1 (de) * 1989-11-09 1995-09-15 Sandoz Ag Heteroatome enthaltende tricyclische verbindungen.
US5352671A (en) * 1989-11-09 1994-10-04 Sandoz Ltd. Heteroatoms-containing tricyclic compounds
GB2252041A (en) * 1991-01-23 1992-07-29 Fujisawa Pharmaceutical Co Use of macrolide compounds in treatment of autoimmune myocarditis
AU664178B2 (en) * 1991-03-19 1995-11-09 Vithal J. Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US5247076A (en) * 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
GB9203636D0 (en) * 1992-02-19 1992-04-08 Lucas Ind Plc Fuel pumping apparatus
KR0155015B1 (ko) * 1992-10-21 1998-12-01 고우야 마사시 2-아미노-1,3-프로판디올 화합물 및 면역 억제제
WO1994021642A1 (en) 1993-03-17 1994-09-29 Abbott Laboratories Macrocyclic amide and urea immunomodulators
US5590460A (en) * 1994-07-19 1997-01-07 Tessera, Inc. Method of making multilayer circuit
DE69524962T4 (de) 1994-08-22 2003-08-28 Mitsubishi Pharma Corp., Osaka Benzolderivate und deren medizinische verwendung
GB9521322D0 (en) 1995-10-17 1995-12-20 Sandoz Ltd Organic compounds
JPH11209277A (ja) 1998-01-19 1999-08-03 Yoshitomi Pharmaceut Ind Ltd 医薬組成物
GB9624038D0 (en) 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
ES2240868T3 (es) * 1997-04-04 2005-10-16 Mitsubishi Pharma Corporation Compuesto de 2-aminopropano -1,3-diol, su uso farmaceutico e intermedios en su sintesis.
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
JP4627356B2 (ja) * 1999-06-30 2011-02-09 昭 松森 ウイルス性心筋炎の予防または治療薬剤
GB0003932D0 (en) 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
JP2004523275A (ja) 2000-12-22 2004-08-05 アバンテク バスキュラー コーポレーション 治療能力のある薬剤の送達

Similar Documents

Publication Publication Date Title
ES2521672T3 (es) Formulaciones farmacéuticas para el tratamiento del cáncer
JP2005506352A5 (enExample)
RU2007105568A (ru) Эффективный способ использования лекарственных средств и способ предотвращения выраженности побочных эффектов
JP2008514732A5 (enExample)
JP2004531517A5 (enExample)
JP2008521827A5 (enExample)
RU99112577A (ru) Новое применение 1,3-пропандиольных производных
US20080015261A1 (en) Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function
ES2356986T3 (es) Agentes antitumorales.
EP4494701A3 (en) New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
TW202617156A (zh) 用於治療進行性纖維化間質性肺病之新穎口服醫藥組合物及劑量療法
RU2004131214A (ru) Способы лечения когнитивных расстройств
RU2005131845A (ru) Способ лечения легкого ухудшения познавательной способности и предотвращения или задержки начала болезни альцгеймера
JP2002539089A5 (enExample)
RU2005133665A (ru) Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств
RU2006138495A (ru) Использование агонистов рецепторов, активируемых пролифератором пероксисомы дельта для лечения рс и других демиелинизирующих заболеваний
JP2023502053A5 (enExample)
JPH1036365A5 (enExample)
RU2002102076A (ru) Фармацевтическая композиция, содержащая сибутрамин и орлистат
CN1870989A (zh) 用于治疗眼科疾病的香豆素衍生物
JP2002522462A5 (enExample)
JP2003534318A5 (enExample)
JP2003534317A5 (enExample)
JP2021529189A5 (enExample)
RU2009149637A (ru) Композиции, применимые для лечения гастроэзофагеальной рефлюксной болезни